ArticleACS omega2021

Retraction of "Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis".

Yanqiao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.